Skip to main content
Nicholas Brownell, MD, Cardiology, Los Angeles, CA

Nicholas Keisuke Brownell MD (He/Him)


Clinical Instructor

Join to View Full Profile
  • 100 Medical PlazaSuite 630WLos Angeles, CA 90095

  • Phone+1 310-825-9011

  • Fax+1 310-825-9011

Dr. Brownell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Nicholas Brownell is a clinical instructor in cardiology at UCLA. He received his medical degree from Emory University School of Medicine and completed his residency in internal medicine at UT Southwestern. He was a cardiology research fellow at UCLA David Geffen School of Medicine from 2019-2024, and is completing a PhD in Health Policy and Management. He has been in practice for 9 years.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2019 - 2024
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2015 - 2018
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2015
  • University of Pennsylvania
    University of PennsylvaniaB.S., Bioengineering, Cum Laude, 2006 - 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • TX State Medical License
    TX State Medical License 2017 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Cardiac Arrest: When the Heart Stops, Save Lives with High-Quality CPRSeptember 2023
  • Simultaneous Versus Sequential Initiation of HFrEF TherapiesMarch 2022
  • VERTIS CV Trial: Heterogeneity in Clinical Benefits of Sodium-glucose Cotransporter-2 Inhibitors for Patients with Type II Diabetes?September 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: